论文部分内容阅读
As growing promise in engineered immune cells for cancer therapy,for example,Chimeric Antigen Receptors T cells (CAR-T) can recognize and eliminate tumor cells expressing specific antigens,optimal management of their toxicities becomes increasingly important.